| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $81K | +5.2% |
| Cost of Revenue | $164K | +100.0% |
| R&D Expense | $13.2M | -10.6% |
| SG&A Expense | $16.7M | +3.6% |
| Operating Income | -$36.5M | +0.4% |
| Interest Expense | $9K | -67.9% |
| Pre-tax Income | -$31.9M | +2.9% |
| Income Tax | $0 | — |
| Net Income | -$31.9M | +2.9% |
| EPS (Basic) | -$0.67 | +32.3% |
| EPS (Diluted) | -$0.67 | +32.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | -2.4% |
| Short-term Investments | $35.3M | -16.4% |
| Accounts Receivable | $12K | -64.7% |
| Current Assets | $40.8M | -14.3% |
| Total Assets | $101.9M | +40.5% |
| Current Liabilities | $24.2M | -2.3% |
| Total Liabilities | $26.5M | +7.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.6M | -80.6% |
| Capital Expenditures | $726K | +1196.4% |
| Investing Cash Flow | -$28.5M | -342.7% |
| Financing Cash Flow | $54.0M | +1970.8% |
| Free Cash Flow | -$26.3M | -85.0% |
| $75.4M |
| +57.7% |